T.L. Hardy

429 total citations
10 papers, 206 citations indexed

About

T.L. Hardy is a scholar working on Epidemiology, Pharmacology and Hepatology. According to data from OpenAlex, T.L. Hardy has authored 10 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Pharmacology and 4 papers in Hepatology. Recurrent topics in T.L. Hardy's work include Drug-Induced Hepatotoxicity and Protection (4 papers), Liver Disease and Transplantation (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). T.L. Hardy is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (4 papers), Liver Disease and Transplantation (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). T.L. Hardy collaborates with scholars based in United Kingdom and United States. T.L. Hardy's co-authors include Peter H. Bach, David M. Brown, Christopher J. Stewart, Christopher P. Day, Michael I. Trenell, Linda Errington, David Houghton, Leah Avery, Stuart McPherson and William J. Taylor and has published in prestigious journals such as The Lancet, Kidney International and Journal of Hepatology.

In The Last Decade

T.L. Hardy

10 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T.L. Hardy United Kingdom	6	64	48	48	34	34	10	206
Robert M Russell Türkiye	6	80 1.3×	41 0.9×	17 0.4×	26 0.8×	20 0.6×	7	321
A.D. Mackay United Kingdom	10	35 0.5×	85 1.8×	77 1.6×	41 1.2×	10 0.3×	25	378
Annu Khajuria Canada	7	37 0.6×	106 2.2×	43 0.9×	18 0.5×	20 0.6×	10	365
Gilbert R. Park United Kingdom	5	30 0.5×	29 0.6×	20 0.4×	92 2.7×	10 0.3×	12	301
Talat Kılıç Türkiye	10	42 0.7×	17 0.4×	19 0.4×	39 1.1×	9 0.3×	20	304
Lana Nežić Bosnia and Herzegovina	10	84 1.3×	58 1.2×	13 0.3×	70 2.1×	7 0.2×	21	302
B. W. Meade United Kingdom	9	64 1.0×	16 0.3×	60 1.3×	34 1.0×	16 0.5×	22	323
G. Leopold Germany	10	47 0.7×	52 1.1×	37 0.8×	9 0.3×	4 0.1×	18	427
Otilia Elena Frăsinariu Romania	9	79 1.2×	13 0.3×	69 1.4×	96 2.8×	22 0.6×	29	276
J. Murison United Kingdom	11	61 1.0×	15 0.3×	61 1.3×	53 1.6×	27 0.8×	17	370

Countries citing papers authored by T.L. Hardy

Since Specialization

Citations

This map shows the geographic impact of T.L. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.L. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.L. Hardy more than expected).

Fields of papers citing papers by T.L. Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.L. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.L. Hardy. The network helps show where T.L. Hardy may publish in the future.

Co-authorship network of co-authors of T.L. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of T.L. Hardy. A scholar is included among the top collaborators of T.L. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.L. Hardy. T.L. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Neilson, Laura J, T.L. Hardy, Mohammed Hussien, et al.. (2021). Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease. Frontline Gastroenterology. 12(7). 578–585. 13 indexed citations

2.

Houghton, David, T.L. Hardy, Christopher J. Stewart, et al.. (2018). Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes. Diabetologia. 61(8). 1700–1711. 75 indexed citations

3.

Hardy, T.L. & Stuart McPherson. (2017). Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD. Current Hepatology Reports. 16(4). 298–307. 9 indexed citations

4.

Tiniakos, Dina, Stuart McPherson, Vlad Ratziu, et al.. (2017). Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ""FIB-C3 Score"" for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort. 3 indexed citations

5.

McPherson, Stuart, Laura Griffiths, T.L. Hardy, et al.. (2012). 1308 THE FIB-4 SCORE RELIABLY EXCLUDES ADVANCED FIBROSIS IN A DIABETIC COHORT WITH NAFLD. Journal of Hepatology. 56. S515–S516. 1 indexed citations

6.

Bach, Peter H. & T.L. Hardy. (1985). Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Kidney International. 28(4). 605–613. 38 indexed citations

7.

Hardy, T.L. & Peter H. Bach. (1984). The effect of N-phenylanthranilic acid-induced renal papillary necrosis on urinary acidification and renal electrolyte handling. Toxicology and Applied Pharmacology. 75(2). 265–277. 21 indexed citations

8.

Hardy, T.L.. (1970). Identification of cells exfoliated from the rat kidney in experimental nephrotoxicity.. Annals of the Rheumatic Diseases. 29(1). 64–66. 4 indexed citations

9.

Brown, David M. & T.L. Hardy. (1968). SHORT‐TERM STUDY OF THE EFFECT OF PHENACETIN, PHENAZONE AND AMIDOPYRINE ON THE RAT KIDNEY. British Journal of Pharmacology and Chemotherapy. 32(1). 17–24. 40 indexed citations

10.

Hardy, T.L.. (1953). WHAT IS ULCERATIVE COLITIS ?. The Lancet. 262(6776). 88–89. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact